Skip to main content
Log in

Anti-inflammatory effects of muramyl dipeptide in experimental models of acute inflammation

  • Immunosuppression and Inflammation
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

Synthetic muramyl dipeptide,N-acetylmuramyl-l-alanyl-d-isoglutamine (MDP), has been tested for activity against acute inflammation. In all models employed (Bayol + Arlacel paw oedema in rats, carrageenan pleurisy in rats, and carrageenan of dextran paw oedema in mice), MDP given in admixture with the phlogistic agents significantly lowered the resulting inflammatory reaction by about 30–40%. 0.1–0.2 mg of MDP per animal was applied. The mechanism of anti-inflammatory activity of this substance remains unknown.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. F. Elouz, A. Adam, R. Ciorbaru andE. Lederer,Minimal structure requirements for adjuvant activity of bacterial peptidoglycan derivatives, Biochem. biophys. Res. Commun.59, 1317–1325 (1974).

    PubMed  Google Scholar 

  2. S. Kotani, Y. Watanabe, F. Kinoshita, T. Shimono, I. Morisaki, T. Shiba, S. Kusumoto, Y. Tarumi andK. Ikenaka,Immunoadjuvant activities of synthetic N-acetylmuramyl-peptides or-amino acids, Biken's J.18, 105–111 (1975).

    Google Scholar 

  3. F. Audibert andL. Chedid,Distinctive adjuvanticity of synthetic analogs of mycobacterial watersoluble components, Cell. Immunol.21, 243–249 (1976).

    PubMed  Google Scholar 

  4. I. Azuma, K. Sugimura, T. Taniyama, M. Ymawaki, Y. Yamamura, S. Kusumoto, S. Okada andT. Shiba,Adjuvant activity of mycobacterial fractions. Immunological properties of synthetic N-acetylmuramyldipeptide and related compounds, Infect. Immun.14, 18–27 (1976).

    PubMed  Google Scholar 

  5. I. Azuma, K. Sugimura, Y. Yamamura, S. Kusumoto, Y. Tarumi andT. Shiba,Adjuvant activity of synthetic cell-wall peptidoglycan subunits on monoazobenzenearsonate-N-acetyl-l-tyrosine and bacterial alfa-amylase in guinea pigs, Jpn. J. Microbiol.20, 63–66 (1976).

    PubMed  Google Scholar 

  6. Y. Yamamura, I. Azuma, K. Sugimura, S. Kusumoto andT. Shiba,Immunological activity of synthetic cell wall peptidoglycan subunits, Proc. Japan Acad.52, 58–61 (1976).

    Google Scholar 

  7. A. Adam, M. Devys, V. Souvannavong, P.J. Choay andE. Lederer,Correlation of structure and adjuvant activity of N-acetylmuramyl-l-alanyl-d-isoglutamine (MDP), its derivatives and analogues. Antiadjuvant and competition profiles of stereoisomers. Biochem. biophys. Res. Commun.,72, 339–346 (1976).

    PubMed  Google Scholar 

  8. A. Adam, J.-F. Petit, P. Lefrancier andE. Lederer,Muramyl peptides. Chemical structure, biological activity and mechanism of action, Mol. Cell. Biochem.41, 27–47 (1981).

    PubMed  Google Scholar 

  9. L. Chedid, C. Carelli andF. Audibert,Recent developments concerning muramyl dipeptide, a synthetic immunoregulating molecule J. reticuloendothel. Soc.26 (Suppl.), 631–641 (1979).

    PubMed  Google Scholar 

  10. D.E.S. Stewart-Tull,The immunological activities of bacterial peptidoglycans, Ann. Rev. Microbiol.34, 311–340 (1980).

    Google Scholar 

  11. S. Nagao andA. Tanaka,Muramyl dipeptide-induced adjuvant arthritis, Infect. Immun.28, 624–626 (1980).

    PubMed  Google Scholar 

  12. O. Kohashi, A. Tanaka, S. Kotani, T. Shiba, S. Kusumoto, K. Yokogawa, S. Kawata andA. Ozawa,Arthritis-inducing ability of a synthetic adjuvant, N-acetylmuramyl peptides and bacterial disaccharide peptides related to different oil vehicles and their composition, Infect. Immun.29, 70–75 (1980).

    PubMed  Google Scholar 

  13. Z. Zidek, K. Mašek andZ. Jiřička,Arthritogenic activity of a synthetic immunoadjuvant, muramyl dipeptide, Infect. Immun.35, 674–679 (1982).

    PubMed  Google Scholar 

  14. B.J. Winer,Statistical Principles in Experimental Design, p. 241. McGraw-Hill Book Company, New York 1962.

    Google Scholar 

  15. S.M. Wahl, L.M. Wahl, J.B. McCarthy, L. Chedid andS.E. Mergenhagen,Macrophage activation by mycobacterial water soluble compounds and synthetic muramyl dipeptide, J. Immun.122, 2226–2231 (1979).

    PubMed  Google Scholar 

  16. M. Parant, G. Riveau, F. Parant, C.A. Dinarello, S.M. Wolff andL. Chedid,Effect of indomethacin on increased resistance to bacterial infection and on febrile responses induced by muramyl dipeptide, J. infect. Dis.142, 708–715 (1980).

    PubMed  Google Scholar 

  17. K. Mašek, G. Riveau, M. Parant andL. Chedid,The involvement of prostaglandin synthetase system in muramyl dipeptide (MDP)-induced fever (to be published).

  18. P.A. Ward,The inflammatory mediators, Ann. N.Y. Acad. Sci.221, 290–298 (1974).

    PubMed  Google Scholar 

  19. G. Thomas andG.B. West,Aminoacids and inflammation, Br. J. Pharmac.47, 662P (1973).

  20. P. Jain andN.K. Khanna,Evaluation of anti-inflammatory and analgestic properties of l-glutamine, Agents and Actions11, 243–249 (1981).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zídek, Z., Mašek, K. & Šedivý, F. Anti-inflammatory effects of muramyl dipeptide in experimental models of acute inflammation. Agents and Actions 14, 72–75 (1984). https://doi.org/10.1007/BF01966836

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01966836

Keywords

Navigation